| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Terns Pharmaceuticals, Inc. (TERN) has 10 insiders with recent SEC Form 4 filings, including 5 buys and 9 sells. TERN is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 296.5K | $15.70M | - | |
| Other | 112.5K | $5.96M | - | |
| CFO | 101.8K | $5.39M | - | |
| Dir | 45.0K | $2.38M | - | |
| Dir | 2.8K | $149.7K | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Jan 6, 2025 | Vignola Mark J.67 | Chief Financial Officer | Sell | 17,188 | $5.76 | $99,023.52 | -9.8% | -65.0% | +571.1% | |
| Jan 6, 2025 | Quigley Jill M.63 | Director | Sell | 15,000 | $5.76 | $86,460.23 | -63.1% | -65.0% | +571.1% | |
| Jan 2, 2025 | Kuriakose Emil | Chief Medical Officer | Sell | 4,481 | $5.71 | $25,607.12 | -7.6% | -56.1% | +607.4% | |
| Dec 5, 2024 | Burroughs Amy L.57 | Chief Executive Officer | Buy | 15,450 | $7.15 | $110,467.50 | +423.4% | -43.6% | +355.9% | |
| Nov 30, 2024 | Jung Melita Sun | Chief Business Officer | Buy | 2,250 | $5.11 | $11,497.50 | New | -40.9% | +341.2% | |
| Nov 30, 2024 | Burroughs Amy L.57 | Chief Executive Officer | Buy | 510 | $5.11 | $2,606.10 | +2.7% | -40.9% | +341.2% | |
| Sep 12, 2024 | Lu Hongbo59 | Director | Buy | 476,190 | $10.50 | $4,999,995.00 | +250.0% | -29.5% | -24.0% | |
| Sep 10, 2024 | Vignola Mark J.67 | Chief Financial Officer | Sale+OE | 10,000 | $11.00 | $110,000.00 | -9.8% | -41.4% | -33.5% | |
| Sep 9, 2024 | Quigley Jill M.63 | Director | Sale+OE | 17,235 | $10.00 | $172,350.00 | -53.5% | -27.9% | -17.2% | |
| Aug 2, 2024 | Quigley Jill M.63 | Director | Sell | 15,000 | $7.57 | $113,580.07 | -27.9% | -8.0% | -26.7% |